National Survey Shows 1 In 10 Children Use Cough/Cold OTCs Each Week
This article was originally published in The Tan Sheet
Executive Summary
A long-term study underscores possible risks from OTC pediatric cough/cold products and emphasizes the significance of FDA's ongoing review of the medicines' safety and efficacy for 2- to 11-year-old children
You may also be interested in...
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says
Pediatric Cough/Cold “Reverse Switch” Will Not Increase Safety – CHPA
A potential "reverse switch" of pediatric cough/cold OTC drugs to prescription status would not address concerns about efficacy or misuse of the products, the Consumer Healthcare Products Association says